Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

التفاصيل البيبلوغرافية
العنوان:	Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)
المؤلفون:	Syme, R, Stewart, D^{Aff2, Aff4}, Rodriguez-Galvez, M, Luider, J, Auer, Y, Klassen, J, Morris, D^{Aff1, Aff2, Aff4}, Brown, C^{Aff1, Aff2, Aff4}, Russell, J^{Aff2, Aff4}, Glück, S^{Aff1, Aff2, Aff3, Aff4}
المصدر:	Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 32(3):307-311
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	02683369 14765365
DOI:	10.1038/sj.bmt.1704133